Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.
04/10/11Neuralstem shares jump over 13% on new stem cell patent
16/12/10Neuralstem Receives FDA Approval to Start Phase Ia Trial for Depression Drug
14/09/10Study Shows Neuralstem’s Stem Cells May Have Application To Treating Stroke
Recent Sector News
U.S. stocks were mostly lower on Tuesday afternoon as September gets underway, as Ukraine continues to remain an uncertain situation for markets.
Cardiome Pharma's (NASDAQ:CRME) (TSE:COM) shares swung higher on Monday even after the specialty pharma company posted a Q2 wider net loss, as revenues surged due to strong sales from its Brinavess cardiology drug on the back of an aggressive marketing and promotional push.
Shares of Tekmira Pharmaceuticals (NASDAQ:TKMR) (TSE:TKM) were jumping on Friday as the the FDA has modified the full clinical hold on its TKM-Ebola drug to a partial clinical hold, allowing the biopharmaceutical company to potentially make the drug available to patients infected with the virus.
The company, in a statement released earlier today, told investors it has signed a memorandum of understanding to form a "joint venture distribution agreement" with ACGT Corp and associates, a provider of DNA services in Canada with strong ties to China.
Tweed Marijuana's (CVE:TWD) shares rallied over 5 percent on Thursday after the company said it will be releasing up to 18 additional marijuana varieties beginning next week, for sale in August and September.
Kane Biotech's (CVE:KNE) shares added more than 18 percent after the company said it has obtained approval from Health Canada for its dermatological products DispersinB skin cream and shampoo for human use.
Investors interested in Neuralstem recently viewed
- Advanced Oncotherapy (AIM: AVO) .
- Supreme Pharmaceuticals (CSE: SL) Targeting opportunities in the medical marijuana and obesity sectors
- e-Therapeutics plc (AIM: ETX) Systems Biology Drug Discovery
- Medical Australia Limited (ASX: MLA) Medical devices developed, manufactured and distributed in Australia.
- Horizon Discovery Group (AIM: HZD) .